HTR3A and irritable bowel syndrome: Approximately 90–95% of 5-HT is produced in the gut, and 5-HT exerts its biological effects by binding to a variety of 5-HT receptors, of which 5-HT3 and 5-HT4 have been implicated in the pathogenesis of IBS [54].